How should we define and classify exacerbations in chronic obstructive pulmonary disease?

Area of Science:

• Pulmonary Medicine
• Respiratory Disease Research

Background:

• Chronic obstructive pulmonary disease (COPD) is a progressive lung disease.
• COPD exacerbations are acute symptom worsening events with significant clinical impact.
• Exacerbations can occur across all COPD severity levels.

Purpose of the Study:

• To highlight the clinical relevance and prognostic implications of COPD exacerbations.
• To introduce the 'exacerbator' phenotype as defined by the GesEPOC guideline.
• To emphasize the need for standardized tools for exacerbation detection and diagnosis.

Main Methods:

• Review of the GesEPOC guideline definitions and insights.
• Discussion of criteria for defining COPD exacerbations.
• Exploration of diagnostic tools including clinical questionnaires and biomarkers.

Main Results:

• The GesEPOC guideline defines COPD phenotypes, including the 'exacerbator' (≥2 moderate-severe exacerbations/year).
• A precise definition of exacerbation requires symptom increase post-stabilization and consideration of social/therapeutic factors.
• Validated questionnaires and biomarkers are crucial for homogeneous exacerbation definition and diagnosis.

Conclusions:

• Accurate COPD exacerbation identification is vital for appropriate management.
• The 'exacerbator' phenotype requires specific attention.
• Standardized diagnostic approaches improve patient care and clinical study design.